Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort

Journal of Rheumatology

Volumn 41, Issue 4, 2014, Pages 680-687

  Bartels, Christie M ^a   Buhr, Kevin A ^a   Goldberg, Jerry W ^b   Bell, Carolyn L ^a   Visekruna, Maja ^c   Nekkanti, Swapna ^d   Greenlee, Robert T ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MARSHFIELD CLINIC   (United States)

^c Division of Internal Medicine Pediatrics Health East Woodbury Clinic   (United States)

^d Springfield Clinic   (United States)

Author keywords

Cardiovascular system mortality; Cohort study; Epidemiology; Incidence; Systemic lupus erythematosus

Indexed keywords

HYDROXYCHLOROQUINE; STEROID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SEX RATIO; SMOKING; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVAL; KAPLAN MEIER METHOD; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; SURVIVAL;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84897449619     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130874     Document Type: Article

References (30)

1. Alarcon GS, McGwin G Jr., Bastian HM, Roseman J, Lisse J, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001;45:191-202.
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003; 82:299-308.
3. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine 2006;85:147-56.
4. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7.
5. Alonso MD, Martinez-Vazquez F, de Teran TD, Miranda-Filloy JA, Dierssen T, Blanco R, et al. Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus 2012;21:1135-48.
6. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
7. Duran S, Apte M, Alarcon GS. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007;99:1196-8.
8. Michet CJ Jr., McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
9. Uramoto KM, Michet CJ Jr., Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42:46-50.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
11. Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005;14:862-6.
12. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
13. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? Am J Med Qual 2004;19:201-6.
14. Rector TS, Wickstrom SL, Shah M, Thomas Greenlee N, Rheault P, Rogowski J, et al. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res 2004;39:1839-57.
15. Buccaneer Computer Systems and Service Inc. Chronic condition data warehouse user manual. Warrenton, VA: Buccaneer Computer Systems and Service Inc.; 2009.
16. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
17. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
18. Minnesota Department of Health. Minnesota Stroke Registry: Case Ascertainment Protocol and Case Definition. 2010 [Internet. Accessed January 14, 2014.] Available from: www.mnstrokeregistry.org/documents/MSRCaseAscertainment Protocol100119-000.pdf.
19. Lim SS, Drenkard C, McCune WJ, Helmick CG, Gordon C, Deguire P, et al. Population-based lupus registries: advancing our epidemiologic understanding. Arthritis Rheum 2009;61:1462-6.
20. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 2004;83:348-59.
21. Lalani S, Pope J, de Leon F, Peschken C. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol 2010;37:38-44.
22. Magder LS, Petri M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 2012;176:708-19.
23. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006;119:700-6.
24. Kiani AN, Magder L, Petri M. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity. J Rheumatol 2008;35:1300-6.
25. Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. J Rheumatol 2004;31:713-9.
26. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
27. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr., Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
28. Larson SL, Fleishman JA. Rural-urban differences in usual source of care and ambulatory service use: analyses of national data using Urban Influence Codes. Med Care 2003;41:III65-74.
29. Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991;50:702-5.
30. 2011-2012 Wisconsin Collaborative for Healthcare Quality (WCHQ) Reports. 2012 [Internet. Accessed January 14, 2014.] Available from: http://www.wchq.org/ reporting/